Umeå University Hospital | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)	Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Phase 3	2026-04-30		NCT04608318
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries	Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Craniocerebral Trauma, Neoplasms by Site, Parkinson disease, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, brain injury, cardiovascular disorder, central nervous system cancer, central nervous system disorder, cerebrovascular disorder, demyelinating disease, epilepsy, immune system disorder, injury, movement disorder, multiple sclerosis, neoplasm, nervous system disorder, nervous system injury, neurodegenerative disease, parkinsonian disorder, stroke disorder, synucleinopathy, vascular disorder	Recruiting	Not stated	2026-04-01		NCT05819008
BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 3	2022-05-25		NCT04079049